A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais
- 14 February 2000
- Vol. 18 (15) , 1448-1455
- https://doi.org/10.1016/s0264-410x(99)00421-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Nationwide Surveillance of HIV-1 Prevalence and Subtype in Young Thai MenJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Motivation, Recruitment, and Screening of Volunteers for a Phase I/II HIV Preventive Vaccine Trial in ThailandJAIDS Journal of Acquired Immune Deficiency Syndromes, 1998
- Safety Profile of Phase I and II Preventive HIV Type 1 Envelope Vaccination: Experience of the NIAID AIDS Vaccine Evaluation GroupAIDS Research and Human Retroviruses, 1997
- Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind TrialAnnals of Internal Medicine, 1996
- Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1996
- The 100% Condom Program in ThailandAIDS, 1996
- Declining prevalence of HIV-1 infection in young Thai menAIDS, 1995
- Clinical And Immunologic Responses To Human Immunodeficiency Virus (HIV) Type LSF2 gp120 Subunit Vaccine Combined With MF59 Adjuvant With Or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine In Non-HIV-Infected Human VolunteersThe Journal of Infectious Diseases, 1994
- Two Antigenically Distinct Subtypes of Human Immunodeficiency Virus Type 1: Viral Genotype Predicts Neutralization SerotypeThe Journal of Infectious Diseases, 1994
- Genetic Comparison of HIV-1 Isolates from Africa, Europe, and North AmericaAIDS Research and Human Retroviruses, 1992